Amundi Lowers Stake in Omega Healthcare Investors, Inc. $OHI

Amundi cut its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 71.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 576,669 shares of the real estate investment trust's stock after selling 1,462,578 shares during the period. Amundi owned about 0.20% of Omega Healthcare Investors worth $22,288,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of OHI. Ameriprise Financial Inc. lifted its position in Omega Healthcare Investors by 3.9% during the fourth quarter. Ameriprise Financial Inc. now owns 776,715 shares of the real estate investment trust's stock valued at $29,398,000 after purchasing an additional 28,921 shares in the last quarter. Baird Financial Group Inc. lifted its position in shares of Omega Healthcare Investors by 0.8% in the fourth quarter. Baird Financial Group Inc. now owns 50,492 shares of the real estate investment trust's stock worth $1,911,000 after buying an additional 380 shares in the last quarter. Cetera Investment Advisers lifted its position in shares of Omega Healthcare Investors by 5.6% in the fourth quarter. Cetera Investment Advisers now owns 93,096 shares of the real estate investment trust's stock worth $3,524,000 after buying an additional 4,943 shares in the last quarter. Cresset Asset Management LLC purchased a new stake in shares of Omega Healthcare Investors in the fourth quarter worth about $201,000. Finally, CoreCap Advisors LLC lifted its position in shares of Omega Healthcare Investors by 177.3% in the fourth quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after buying an additional 1,009 shares in the last quarter. 65.25% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director owned 18,654 shares of the company's stock, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.50% of the company's stock.

Analysts Set New Price Targets

Several brokerages have weighed in on OHI. Mizuho boosted their price objective on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday. Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. Royal Bank Of Canada boosted their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Truist Financial boosted their price objective on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research note on Wednesday, September 3rd. Finally, Raymond James Financial reissued an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Five equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $43.75.

Omega Healthcare Investors Trading Down 0.0%

Shares of OHI traded down $0.01 during mid-day trading on Friday, reaching $42.49. 1,550,013 shares of the company's stock traded hands, compared to its average volume of 1,686,146. The stock has a market cap of $12.53 billion, a P/E ratio of 26.23, a P/E/G ratio of 2.23 and a beta of 0.71. The stock's 50-day moving average is $40.26 and its two-hundred day moving average is $38.24. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company's quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.